Oramed Pharmaceuticals Inc (ORMP)
2.42
+0.09
(+3.86%)
USD |
NASDAQ |
Apr 23, 11:39
Oramed Pharmaceuticals Market Cap: 98.06M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 94.41M |
| April 19, 2024 | 91.98M |
| April 18, 2024 | 89.14M |
| April 17, 2024 | 94.41M |
| April 16, 2024 | 97.25M |
| April 15, 2024 | 98.06M |
| April 12, 2024 | 102.11M |
| April 11, 2024 | 104.54M |
| April 10, 2024 | 107.78M |
| April 09, 2024 | 109.00M |
| April 08, 2024 | 112.24M |
| April 05, 2024 | 105.76M |
| April 04, 2024 | 105.76M |
| April 03, 2024 | 111.43M |
| April 02, 2024 | 113.45M |
| April 01, 2024 | 114.67M |
| March 28, 2024 | 118.32M |
| March 27, 2024 | 114.26M |
| March 26, 2024 | 110.21M |
| March 25, 2024 | 111.83M |
| March 22, 2024 | 117.91M |
| March 21, 2024 | 113.45M |
| March 20, 2024 | 119.94M |
| March 19, 2024 | 114.67M |
| March 18, 2024 | 113.86M |
| Date | Value |
|---|---|
| March 15, 2024 | 118.32M |
| March 14, 2024 | 108.59M |
| March 13, 2024 | 112.24M |
| March 12, 2024 | 115.88M |
| March 11, 2024 | 119.13M |
| March 08, 2024 | 120.75M |
| March 07, 2024 | 115.88M |
| March 06, 2024 | 116.29M |
| March 05, 2024 | 131.51M |
| March 04, 2024 | 131.10M |
| March 01, 2024 | 137.96M |
| February 29, 2024 | 132.72M |
| February 28, 2024 | 137.56M |
| February 27, 2024 | 144.41M |
| February 26, 2024 | 143.20M |
| February 23, 2024 | 139.57M |
| February 22, 2024 | 133.12M |
| February 21, 2024 | 129.49M |
| February 20, 2024 | 127.07M |
| February 16, 2024 | 126.66M |
| February 15, 2024 | 126.66M |
| February 14, 2024 | 126.26M |
| February 13, 2024 | 122.23M |
| February 12, 2024 | 127.87M |
| February 09, 2024 | 114.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.24M
Minimum
Nov 20 2019
1.132B
Maximum
Nov 08 2021
211.84M
Average
113.37M
Median
Market Cap Benchmarks
| Inogen Inc | 160.02M |
| Petros Pharmaceuticals Inc | 4.709M |
| DIH Holding US Inc | 53.92M |
| NovaBay Pharmaceuticals Inc | 2.200M |
| Palatin Technologies Inc | 28.72M |
Market Cap Related Metrics
| PE Ratio | 17.29 |
| PS Ratio | 36.31 |
| Price to Book Value | 0.5986 |
| Price | 2.42 |
| Earnings Yield | 5.79% |